ADMA Biologics Inc (NASDAQ:ADMA)
| 3.80 Delayed Data As of 3:59pm ET |  -0.065 / -1.68%Today’s Change | 1.38 Today|||52-Week Range 3.98 | -2.19% Year-to-Date |
Institutional investors purchased a net $10.8 million shares of ADMA during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 64.68% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
| Other institutional | 41.17% |
| Individual stakeholders | 24.22% |
| Mutual fund holders | 23.51% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 12/31/2022 | ASSENAGON ASSET MANAGEMENT SA (G... Bought 1.3 Million shares of ADMA Biologics Inc |
| 11/30/2022 | KLP KAPITALFORVALTNING AS Bought 31.2 Thousand shares of ADMA Biologics Inc |
| 12/31/2022 | ZÜRCHER KANTONALBANK (INVESTMENT... Bought 20.7 Thousand shares of ADMA Biologics Inc |
Top 10 Owners of ADMA Biologics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| BlackRock Fund Advisors | 5.23% | 11,541,915 | 44,782,630 | +171,875 | +1.51% |
| Caligan Partners LP | 5.22% | 10,264,311 | 39,825,527 | -628,926 | -5.77% |
| Perceptive Advisors LLC | 4.95% | 10,933,387 | 42,421,542 | -587,715 | -5.10% |
| SSgA Funds Management, Inc. | 4.27% | 9,423,422 | 36,562,877 | +6,459,197 | +217.91% |
| The Vanguard Group, Inc. | 4.09% | 9,033,149 | 35,048,618 | +232,646 | +2.64% |
| Boothbay Fund Management LLC | 3.68% | 8,121,153 | 31,510,074 | -2,239,247 | -21.61% |
| D. E. Shaw & Co. LP | 2.65% | 5,843,796 | 22,673,928 | +1,011,404 | +20.93% |
| Velan Capital Investment Manageme... | 2.38% | 5,269,155 | 20,444,321 | -804,443 | -13.24% |
| AWM Investment Co., Inc. | 2.27% | 5,015,000 | 19,458,200 | 0 | 0.00% |
| Stonepine Capital Management LLC | 2.26% | 5,000,000 | 19,400,000 | -2,000,000 | -28.57% |
Top 10 Mutual Funds Holding ADMA Biologics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| SPDR S&P Biotech ETF | 3.94% | 7,757,979 | 30,100,959 | +31,328 | +0.41% |
| Vanguard Total Stock Market Index... | 2.83% | 6,244,828 | 24,229,933 | +628,900 | +11.20% |
| iShares Russell 2000 ETF | 2.10% | 4,125,993 | 16,008,853 | -43,066 | -1.03% |
| Vanguard Extended Market Index Fu... | 1.14% | 2,511,074 | 9,742,967 | +17,262 | +0.69% |
| Bridgeway Small Cap Value Fund | 1.08% | 2,391,000 | 9,277,080 | +2,391,000 | -- |
| Invesco Main Street Small Cap Fun... | 0.95% | 2,107,522 | 8,177,185 | +396,050 | +23.14% |
| iShares Biotechnology ETF | 0.80% | 1,572,501 | 6,101,304 | +5,905 | +0.38% |
| TIAA-CREF Quant Small Cap Equity ... | 0.74% | 1,638,750 | 6,358,350 | -24,800 | -1.49% |
| Fidelity Small Cap Index Fund | 0.67% | 1,471,193 | 5,708,229 | +14,460 | +0.99% |
| Alger Funds - Health Sciences Fun... | 0.62% | 1,378,011 | 5,346,683 | +139,017 | +11.22% |